In a bid to compete with cheaper generics, Danish drugmaker Novo Nordisk on Monday announced a 36 percent and 48 percent price cut for its injectable semaglutide brands Ozympic and Vigovi in India, respectively. However, senior executives told Business Standard that the company is not planning a similar move for its oral semaglutide brand, Rebelsos. … Read more
This article was reviewed by Mike Buhl, MD. If you are using a GLP-1 like semaglutide, you are likely to experience stronger effects of this weight loss drug. You’re making better food choices, moving more, and reaching your health goals. Maybe you’ve even reached your goal weight. But what happens when you decide to stop … Read more
The U.S. Food and Drug Administration announced Thursday that it is approving a new, high-dose Vigovi (semglutide) injection. The 7.2 mg dose, called Vigovi HD, is intended for weight loss and long-term weight loss maintenance in adult patients. This is three times the previous maximum dose of 2.4 mg. This marks the fourth approval in … Read more